SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

From $200 million valuation to insolvency: Insurtech startup Sproutt heading for bankruptcy

April 2024 in Israeli tech funding: Over $1 billion in 20 deals

Remepy raises $10 million Seed round to bring first hybrid drug to market

Full list of Israeli high-tech funding rounds in 2024

Buzz

Most popular

Daily

Weekly

1

Israeli Billionaire Hires Black Cube to Spy on Former Partner Company Vale

2

Cyber startup Oasis secures $35 million Series A extension, doubles valuation

3

"Israel definitely needs to reconsider its strategy towards China"

4

Cyber startup Island doubles valuation to $3 billion in $175 million Series D

5

De Niro to pro-Palestinian protestors: Stop talking nonsense, go home!

Cukierman

3 stories about Cukierman

Dr Laurent Choppe Managing Partner at Cukierman Co Life Sciences

Prepare for a year of M&As in Israeli life sciences companies

28.11.21|Laurent Choppe

Massive fund raising, significant growth in M&A deals and even a first Israeli biomed SPAC; Dr. Laurent Choppe, Managing Partner at Cukierman & Co. Life Sciences, explains the current trends behind the sector's amazing year and discusses what’s next

Dr Laurent Choppe Managing Partner at Cukierman Co Life Sciences

Israel third only to U.S. and China in Covid-19 solutions, says life sciences expert

17.07.20|Allon Sinai

"We don't talk anymore about devices or drugs. We talk about healthtech convergence, which for me is the future," explains Dr. Laurent Choppe, Managing Partner at Cukierman & Co. Life Sciences

אדוארד קוקירמן קטליסט

U.S.-China Trade War an Opportunity for Israeli Tech, Says Venture Capitalist

31.10.19|Lilach Baumer

Edouard Cukierman of Cukierman & Co. and Catalyst sees potential in the mounting trade tensions between the U.S. and China, and thinks Israeli companies should steer clear of Chinese politics